Elixir has conducted five first-in-human clinical studies evaluating the therapeutic effectiveness of the company’s Novolimus-eluting and Myolimus-eluting stent systems. Novolimus and Myolimus are macrocyclic lactones in the same
Based on the precept that ‘form follows function’, the ATS 3f Aortic Bioprosthesis is a stentless pericardial aortic tissue valve that is said to be unlike any other
This approval allows for use of Precedex in non-intubated patients requiring sedation prior to and during surgical and other procedures. The additional indication complements Precedex’s initial approval for
The company has also appointed Elisha Orr, a cancer researcher and the developer of the company’s antibody technology, as the director and chief scientific officer of the Belgian
Vital Signs will become part of GE Healthcare’s clinical systems business, a provider of advanced technologies for patient monitoring, anesthesia delivery and acute respiratory care. The strong strategic
Sodium ferulate by injection is intended for the treatment of cardiovascular disease. It works by inhibiting the gathering of hematoblasts and stretches blood vessels in order to protect
Aldagen is currently conducting a Phase III trial infusing ALD-101 in patients with inherited metabolic disorders undergoing umbilical cord blood transplantation. Cord blood transplantation is commonly used to
The agreement with Bayhill is a part of Juvenile Diabetes Research Foundation’s (JDRF’s) innovative industry discovery and development partnership (IDDP) program, through which JDRF partners with pharmaceutical, biotech,
The patents relate to the company’s ability to create, develop and manufacture antibodies based on its dynamic cross linking (DXL) technology platform. The new patents name InNexus scientists
MedImmune reported the absence of serious, dose-limiting adverse events in the study and concluded that the data also demonstrated an acceptable safety profile for multiple subcutaneous doses of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.